Synopsis
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
With Fermion, start the journey of your innovative API.
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
EU-WC
KDMF
AMI Lifesciences is Driven by Chemistry. Powered by People.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
EU-WC
Inke S.A: APIs manufacturing plant.
Lifecare Labs has been developing innovative products in specialist areas of medicine.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Together we can improve the quality of life
With Fermion, start the journey of your innovative API.
KDMF
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
73
PharmaCompass offers a list of Benserazide Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benserazide Hydrochloride manufacturer or Benserazide Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benserazide Hydrochloride manufacturer or Benserazide Hydrochloride supplier.
PharmaCompass also assists you with knowing the Benserazide Hydrochloride API Price utilized in the formulation of products. Benserazide Hydrochloride API Price is not always fixed or binding as the Benserazide Hydrochloride Price is obtained through a variety of data sources. The Benserazide Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levodopa and Benserazide-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levodopa and Benserazide-2, including repackagers and relabelers. The FDA regulates Levodopa and Benserazide-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levodopa and Benserazide-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levodopa and Benserazide-2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levodopa and Benserazide-2 supplier is an individual or a company that provides Levodopa and Benserazide-2 active pharmaceutical ingredient (API) or Levodopa and Benserazide-2 finished formulations upon request. The Levodopa and Benserazide-2 suppliers may include Levodopa and Benserazide-2 API manufacturers, exporters, distributors and traders.
click here to find a list of Levodopa and Benserazide-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levodopa and Benserazide-2 DMF (Drug Master File) is a document detailing the whole manufacturing process of Levodopa and Benserazide-2 active pharmaceutical ingredient (API) in detail. Different forms of Levodopa and Benserazide-2 DMFs exist exist since differing nations have different regulations, such as Levodopa and Benserazide-2 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levodopa and Benserazide-2 DMF submitted to regulatory agencies in the US is known as a USDMF. Levodopa and Benserazide-2 USDMF includes data on Levodopa and Benserazide-2's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levodopa and Benserazide-2 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levodopa and Benserazide-2 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levodopa and Benserazide-2 Drug Master File in Korea (Levodopa and Benserazide-2 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levodopa and Benserazide-2. The MFDS reviews the Levodopa and Benserazide-2 KDMF as part of the drug registration process and uses the information provided in the Levodopa and Benserazide-2 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levodopa and Benserazide-2 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levodopa and Benserazide-2 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levodopa and Benserazide-2 suppliers with KDMF on PharmaCompass.
A Levodopa and Benserazide-2 CEP of the European Pharmacopoeia monograph is often referred to as a Levodopa and Benserazide-2 Certificate of Suitability (COS). The purpose of a Levodopa and Benserazide-2 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levodopa and Benserazide-2 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levodopa and Benserazide-2 to their clients by showing that a Levodopa and Benserazide-2 CEP has been issued for it. The manufacturer submits a Levodopa and Benserazide-2 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levodopa and Benserazide-2 CEP holder for the record. Additionally, the data presented in the Levodopa and Benserazide-2 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levodopa and Benserazide-2 DMF.
A Levodopa and Benserazide-2 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levodopa and Benserazide-2 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levodopa and Benserazide-2 suppliers with CEP (COS) on PharmaCompass.
A Levodopa and Benserazide-2 written confirmation (Levodopa and Benserazide-2 WC) is an official document issued by a regulatory agency to a Levodopa and Benserazide-2 manufacturer, verifying that the manufacturing facility of a Levodopa and Benserazide-2 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levodopa and Benserazide-2 APIs or Levodopa and Benserazide-2 finished pharmaceutical products to another nation, regulatory agencies frequently require a Levodopa and Benserazide-2 WC (written confirmation) as part of the regulatory process.
click here to find a list of Levodopa and Benserazide-2 suppliers with Written Confirmation (WC) on PharmaCompass.
Levodopa and Benserazide-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levodopa and Benserazide-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levodopa and Benserazide-2 GMP manufacturer or Levodopa and Benserazide-2 GMP API supplier for your needs.
A Levodopa and Benserazide-2 CoA (Certificate of Analysis) is a formal document that attests to Levodopa and Benserazide-2's compliance with Levodopa and Benserazide-2 specifications and serves as a tool for batch-level quality control.
Levodopa and Benserazide-2 CoA mostly includes findings from lab analyses of a specific batch. For each Levodopa and Benserazide-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levodopa and Benserazide-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Levodopa and Benserazide-2 EP), Levodopa and Benserazide-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levodopa and Benserazide-2 USP).
